KD6005
/ Shanghai Kanda Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 02, 2024
A Study of KD6005 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)
(clinicaltrials.gov)
- P1 | N=72 | Recruiting | Sponsor: Shanghai Kanda Biotechnology Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology
January 19, 2024
A Study of KD6005 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)
(clinicaltrials.gov)
- P1 | N=72 | Not yet recruiting | Sponsor: Shanghai Kanda Biotechnology Co., Ltd.
New P1 trial • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology
1 to 2
Of
2
Go to page
1